Literature DB >> 11368076

Insights into mu opioid pharmacology the role of mu opioid receptor subtypes.

G W Pasternak1.   

Abstract

Although mu opioids share many pharmacological characteristics, they also reveal many differences. Many approaches over the years have suggested the existence of multiple mu opioid receptors. The unique selectivities of naloxonazine, for example, provided a way of distinguishing mu₁from mu₂actions. Studies of morphine-6beta-gluruconide suggested that its actions involved yet another mu opioid receptor subtype. The cloning of a mu opioid receptor, MOR-1, provided a way of exploring this possibility at the molecular level. Recent studies have now identified a number of splice variants of this gene that appear to be important in the production of mu opioid analgesia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368076     DOI: 10.1016/s0024-3205(01)01008-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  24 in total

Review 1.  Opioid receptor regulation.

Authors:  Mark von Zastrow
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 2.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

3.  A naloxonazine sensitive (mu1 receptor) mechanism in the parabrachial nucleus modulates eating.

Authors:  Nayla N Chaijale; Vincent J Aloyo; Kenny J Simansky
Journal:  Brain Res       Date:  2008-09-04       Impact factor: 3.252

4.  Bioinformatic analysis of the human mu opioid receptor (OPRM1) splice and polymorphic variants.

Authors:  Lili Xin; Zaijie Jim Wang
Journal:  AAPS PharmSci       Date:  2002

Review 5.  Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management.

Authors:  Folabomi A Oladosu; William Maixner; Andrea G Nackley
Journal:  Mayo Clin Proc       Date:  2015-08       Impact factor: 7.616

6.  Effects of μ-opioid receptor modulation on the hippocampal network activity of sharp wave and ripples.

Authors:  Panagiotis Giannopoulos; Costas Papatheodoropoulos
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

7.  Mapping of a quantitative trait locus for morphine withdrawal severity.

Authors:  Benjamin Kest; Christina A Palmese; Aaron Juni; Elissa J Chesler; Jeffrey S Mogil
Journal:  Mamm Genome       Date:  2004-08       Impact factor: 2.957

8.  Animal-to-human extrapolation of the pharmacokinetic and pharmacodynamic properties of buprenorphine.

Authors:  Ashraf Yassen; Erik Olofsen; Jingmin Kan; Albert Dahan; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

9.  Opiate-agonist induced taste aversion learning in the Fischer 344 and Lewis inbred rat strains: evidence for differential mu opioid receptor activation.

Authors:  Catherine M Davis; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2009-06-07       Impact factor: 3.533

10.  Quantitative and Qualitative Behavioral Measurements to Assess Pain in Axolotls (Ambystoma mexicanum).

Authors:  Jeremy T Llaniguez; Morgan A Szczepaniak; Barry H Rickman; Juri G Gelovani; Gerald A Hish; Tara M Cotroneo
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-01-21       Impact factor: 1.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.